http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100712226-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-18 |
| filingDate | 1999-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100712226-B1 |
| titleOfInvention | 1,2-annealed quinoline derivatives |
| abstract | The present invention provides a compound of formula (I) or a pharmaceutically acceptable acid addition salt or stereochemically isomeric form thereof; To a process for the preparation thereof, a composition comprising the same and a use as a medicament:n n n n n n n n Wheren n n = X 1 -X 2 -X 3 is a trivalent radical of the formula:n n n Is a trivalent radical of the formula:n n n r and s are each independently 0,1,2,3,4 or 5;n n n t is 0,1,2 or 3;n n n Each R 1 and R 2 is independently hydroxy, halo, cyano, C 1-6 alkyl, trihalomethyl, trihalomethoxy, C 2-6 alkenyl, C 1-6 alkyloxy, hydroxy C 1-6 alkyloxy, C 1-6 alkylthio, C 1-6 alkyloxyC 1-6 alkyloxy, C 1-6 alkyloxycarbonyl, aminoC 1-6 alkyloxy, mono- or di (C 1 -6 alkyl) amino, mono- or di (C 1-6 alkyl) aminoC 1-6 alkyloxy, aryl, arylC 1-6 alkyl, aryloxy or arylC 1-6 alkyloxy, hydroxycarbonyl, C 1-6 alkyloxycarbonyl, aminocarbonyl, aminoC 1-6 alkyl, mono- or di (C 1-6 alkyl) aminocarbonyl, mono- or di (C 1-6 alkyl) aminoC 1- 6 alkyl;n n n Two R 1 or R 2 adjacent to each other on a phenyl ring may together independently form a divalent radical of the formula:n n n R 3 is hydrogen, halo, C 1-6 alkyl, cyano, halo C 1-6 alkyl, hydroxy C 1-6 alkyl, cyano C 1-6 alkyl, amino C 1-6 alkyl, C 1-6 Alkyloxy C 1-6 alkyl, C 1-6 alkylthio C 1-6 alkyl, aminocarbonyl C 1-6 alkyl, hydroxycarbonyl, hydroxycarbonylC 1-6 alkyl, C 1-6 alkyloxy CarbonylC 1-6 alkyl, C 1-6 alkylcarbonylC 1-6 alkyl, C 1-6 alkyloxycarbonylC 1-6 alkyl, aryl, arylC 1-6 alkyloxyC 1-6 alkyl, Mono- or di (C 1-6 alkyl) aminoC 1-6 alkyl or a formula —OR 10 , —SR 11 or —NR 11 R 12 ;n n n R 4 is optionally substituted imidazolyl;n n n Aryl is optionally substituted phenyl or naphthalenyl. |
| priorityDate | 1998-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 264.